Abstract
Recent advances in fields of medicine and pharmacology provides intensivists with tools to treat critically ill patients ant to search new ways to optimize intensive therapy and new solutions. Vasopressin (AVP) is the first synthetized peptic hormones used for treatment of diabetes insipidus and gastrointestinal bleeding for last fifty years. Oliver and Shaffer discovered it in 1895 when they found that hypophysis extract infused to laboratory animals leads to elevation of arterial blood pressure, and Farini and Felden described its antidiuretic property in treatment of diabetes insipidus. Vincent du Vigneaud was the first to synthetize vasopressin in 1954, but its positive effect on vasoplegic syndrome was described only in 1997. Since that time number of scientific researchers had been held aimed to clarify its effectiveness, side effects, minimal safe dosages and therapy initiation criteria.
References
- Vincent V., Duane T.G., Katsoyannis P.G. A synthetic preparation possessing biological properties associated with argininevasopressin. J. Am. Chem. Soc. 1954; 76: 4751–2. DOI: 10.1021/ja01647a089
- Oliver G., Schäfer E.A. On the physiological action of extracts of pituitary body and certain other glandular organs. J. Physiol. 1895; 18 (3): 277–9. DOI: 10.1113/jphysiol.1895.sp000565
- Robert A.T., John G.P., Vincent D.V. The purification and the amino acid content of vasopressin preparations. Biol. Chem. 1951; 191 (1): 21–8. https://www.jbc.org/article/S0021- 9258(18)50947-9/pdf (дата обращения 17.05.2022 /accessed May 17, 2022).
- Liu Z.M., Chen J., Kou Q., Lin Q., Huang X., Tang Z. et al. Terlipressin versus norepinephrine as infusion in patients with septic shock: a multicentre, randomised, double-blinded trial. Intensive Care Med. 2018; 44 (11): 1816–25. DOI: 10.1007/s00134-018-5267-9
- Scheeren T.W.L., Bakker J., De Backer D., Annane D., Asfar P., Boerma E.C. et al. Current use of vasopressors in septic shock. Ann. Intensive Care. 2019; 9 (1): 20. DOI: 10.1186/s13613-019-0498-7
- Evans L., Rhodes A., Alhazzani W., Antonelli M., Coopersmith C.M., French C. et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021; 47 (11): 1181–247. DOI: 10.1007/s00134-021-06506-y
- Raghavan V.R., da Cruz E.M., Kaufman J., Osorio Lujan S. International survey on the use of arginine vasopressin in the postoperative management of single ventricle patients. Front. Pediatr. 2021; 9: 669055. DOI: 10.3389/fped.2021.669055
- Koshman S.L., Zed P.J., Abu-Laban R.B. Vasopressin in cardiac arrest. Ann. Pharmacother. 2005; 39 (10): 1687–92. DOI: 10.1345/aph.1G187
- Schummer C., Wirsing M., Schummer W. The pivotal role of vasopressin in refractory anaphylactic shock. Anesth. Analg. 2008; 107 (2): 620–4. DOI: 10.1213/ane.0b013e3181770b42
- Williams S.R., Denault A.Y., Pellerin M., Martineau R. Vasopressin for treatment of shock following aprotinin administration. Can. J. Anaesth. 2004; 51 (2): 169–72. DOI: 10.1007/BF03018778
- Di Chiara L., Stazi G.V., Ricci Z., Polito A., Morelli S., Giorni C. et al. Role of vasopressin in the treatment of anaphylactic shock in a child undergoing surgery for congenital heart disease: a case report. J. Med. Case Rep. 2008; 2: 36. DOI: 10.1186/1752-1947-2-36
- Meng L., Williams E.L. Case report: treatment of rocuroniuminduced anaphylactic shock with vasopressin. Can. J. Anaesth. 2008; 55 (7): 437–40. DOI: 10.1007/BF03016310
- Stadlbauer K.H., Wenzel V., Krismer A.C., Voelckel W.G., Lindner K.H. Vasopressin during uncontrolled hemorrhagic shock: less bleeding below the diaphragm, more perfusion above. Anesth. Analg. 2005; 101 (3): 830–2. DOI: 10.1213/01.ANE.0000175217.55775.1C
- Voelckel W.G., Raedler C., Wenzel V., Lindner K.H., Krismer A.C., Schmittinger C.A. et al. Arginine vasopressin, but not epinephrine, improves survival in uncontrolled hemorrhagic shock after liver trauma in pigs. Crit. Care Med. 2003; 31 (4): 1160–5. DOI: 10.1097/01.CCM.0000060014.75282.69
- Haas T., Voelckel W.G., Wiedermann F., Wenzel V., Lindner K.H. Successful resuscitation of a traumatic cardiac arrest victim in hemorrhagic shock with vasopressin: a case report and brief review of the literature. J. Trauma. 2004; 57 (1): 177–9. DOI: 10.1097/01.ta.0000044357.25191.1b
- Erkek N., Senel S., Hizli S., Karacan C.D. Terlipressin saved the life of a child with severe nonvariceal upper gastrointestinal bleeding. Am. J. Emerg. Med. 2011; 29 (1): 133.e5–6. DOI: 10.1016/j.ajem.2010.02.010
- Papoff P., Caresta E., Versacci P., Grossi R., Midulla F., Moretti C. The role of terlipressin in the management of severe pulmonary hypertension in congenital diaphragmatic hernia. Paediatr. Anaesth. 2009; 19 (8): 805–6. DOI: 10.1111/j.1460-9592.2009.03078.x
- Stathopoulos L., Nicaise C., Michel F., Thomachot L., Merrot T., Lagier P., Martin C. Terlipressin as rescue therapy for refractory pulmonary hypertension in a neonate with a congenital diaphragmatic hernia. J. Pediatr. Surg. 2011; 46 (2): e19–21. DOI: 10.1016/j.jpedsurg.2010.10.006
- Filippi L., Gozzini E., Daniotti M., Pagliai F., Catarzi S., Fiorini P. Rescue treatment with terlipressin in different scenarios of refractory hypotension in newborns and infants. Pediatr. Crit. Care Med. 2011; 12 (6): e237–41. DOI: 10.1097/PCC.0b013e3181fe304c
- Scheurer M.A., Bradley S.M., Atz A.M. Vasopressin to attenuate pulmonary hypertension and improve systemic blood pressure after correction of obstructed total anomalous pulmonary venous return. J. Thorac. Cardiovasc. Surg. 2005; 129 (2): 464–6. DOI: 10.1016/j.jtcvs.2004.06.043
- Landry D.W., Levin H.R., Gallant E.M., Seo S., Alessandro D.D'., Oz M.C., Oliver J.A. Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit. Care Med. 1997; 25: 1279–82. DOI: 10.1097/00003246-199708000-00012
- Dunser M.W., Matr A.J., Ulmer H., Knotzer H., Sumann G., Pajk W. et al. Arginine vasopressin in advanced vasodilatory shock. A prospective randomized controlled study. Circulation. 2003; 107: 2313–9. DOI: 10.1161/01.CIR.0000066692.71008.BB
- Argenziano M., Chen J.M., Choudhri A.F., Cullinane S., Garfein E., Weinberg A. D. et al. Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of novel pressor agent. J. Thorac. Cardiovasc. Surg. 1998; 116: 973–80. DOI: 10.1016/S0022-5223(98)70049-2
- Eyraud D., Brabant S., Nathalie D., Fléron M.H., Gilles G., Bertrand M., Coriat P. The treatment of intraoperative refractory hypotension with terlipressin in patients chronically treated with an antagonist of the renin-angiotensin system. Anesth. Analg. 1999; 88: 980–4. DOI: 10.1097/00000539-199905000-00003
- Dunser M.W., Mayr A.J., Stallinger A., Ulmer N.J., Hasibeder W.R. Cardiac performance during vasopressin infusion in post cardiotomy shock. Intensive Care Med. 2002; 28: 746–51. DOI: 10.1007/s00134-002-1265-y
- O’Brien A., Clapp L., Singer M. Terlipressin for norepinephrine-resistant septic shock. Lancet. 2002; 359: 1209–10.
- Bernadich C., Bandi J.C., Melin P., Bosch J. Effects of F-180, a new selective vasoconstrictor peptide, compared with terlipressin and vasopressin on systemic and splanchnic hemodynamics in a rat model of portal hypertension. Hepatology. 1998; 27 (2): 351–6. DOI: 10.1002/hep.510270206
- Morelli A., Ertmer C., Rehberg S., Lange M., Orecchioni A., Cecchini V. et al. Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study. Crit. Care. 2009; 13 (4): R130. DOI: 10.1186/cc7990
- Burton G.L., Kaufman J., Goot B.H., da Cruz E.M. The use of arginine vasopressin in neonates following the Norwood procedure. Cardiol. Young. 2011; 21 (5): 536–44. DOI: 10.1017/S1047951111000370
- Matok I., Rubinshtein M., Levy A., Vardi A., Leibovitch L., Mishali D. et al. Terlipressin for children with extremely low cardiac output after open heart surgery. Ann. Pharmacother. 2009; 43 (3): 423–9. DOI: 10.1345/aph.1L199
- Farias J.S., Villarreal E.G., Flores S., Mastropietro C.W., Vogel M., Schulz K. et al. Effects of Vasopressin infusion after pediatric cardiac surgery: a meta-analysis. Pediatr. Cardiol. 2021; 42 (2): 225–33. DOI: 10.1007/s00246-020-02496-8
- Rodríguez-Nún~ez A., Oulego-Erroz I., Gil-Antón J., PérezCaballero C., López-Herce J., Gaboli M., Milano G. RETSPEDII Working Group of the Spanish Society of Pediatric Intensive Care. Continuous terlipressin infusion as rescue treatment in a case series of children with refractory septic shock. Ann. Pharmacother. 2010; 44 (10): 1545–53. DOI: 10.1345/aph.1P254
- Yildizdas D., Yapicioglu H., Celik U., Sertdemir Y., Alhan E. Terlipressin as a rescue therapy for catecholamine-resistant septic shock in children. Intensive Care Med. 2008; 34 (3): 511–7. DOI: 10.1007/s00134-007-0971-x
About the authors
- Asiyat R. Bachieva, Anesthesiologist-Intensivist; ORCID
- Vyacheslav Yu. Beketovskiy, Head of Department; ORCID
- Alesya G. Ivanova, Junior Researcher, Anesthesiologist-Intensivist; ORCID
- Kseniya A. Markelova, Anesthesiologist-Intensivist; ORCID
